Background: Previous studies have found that patients with lung cancer report worse patient experience compared to other tumour groups. Reasons that may negatively impact patient experience include delays in diagnosis as well as inadequate symptom management. The purpose of this study was to compare the diagnostic timelines and symptom reports of patients with lung and gastrointestinal (GI) cancers.
Methods: This study included patients diagnosed with lung or GI cancers who attended a radiation oncology (RO) consultation and/or received radiation treatment between May and August 2019. Data collected included demographics, dates of diagnostic time points and self-reported symptom scores across 3 time points. A descriptive analysis was completed and the median number of days between time points were compared between tumour groups.
Results: Patients with lung cancer experienced a greater diagnostic delay compared to GI patients, specifically regarding the median number of days between the first investigative test and biopsy, with a difference of 21 days between tumour groups (p<0.05). From RO consultation to the first treatment review appointment, 25% and 4% of lung and GI patients, respectively, reported worsening of symptoms. A greater proportion of lung patients reported worse symptoms scores during treatment compared to GI patients. This varied by specific symptom.
Conclusions: Delays in receiving a diagnosis and worse symptom experience during radiation treatment were demonstrated in this study and may indicate potential targets to improve patient experience.

Figure 1

Figure 2
Loading...
Posted 16 Apr, 2021
Received 15 Jun, 2021
Invitations sent on 11 Apr, 2021
On 15 Mar, 2021
Posted 16 Apr, 2021
Received 15 Jun, 2021
Invitations sent on 11 Apr, 2021
On 15 Mar, 2021
Background: Previous studies have found that patients with lung cancer report worse patient experience compared to other tumour groups. Reasons that may negatively impact patient experience include delays in diagnosis as well as inadequate symptom management. The purpose of this study was to compare the diagnostic timelines and symptom reports of patients with lung and gastrointestinal (GI) cancers.
Methods: This study included patients diagnosed with lung or GI cancers who attended a radiation oncology (RO) consultation and/or received radiation treatment between May and August 2019. Data collected included demographics, dates of diagnostic time points and self-reported symptom scores across 3 time points. A descriptive analysis was completed and the median number of days between time points were compared between tumour groups.
Results: Patients with lung cancer experienced a greater diagnostic delay compared to GI patients, specifically regarding the median number of days between the first investigative test and biopsy, with a difference of 21 days between tumour groups (p<0.05). From RO consultation to the first treatment review appointment, 25% and 4% of lung and GI patients, respectively, reported worsening of symptoms. A greater proportion of lung patients reported worse symptoms scores during treatment compared to GI patients. This varied by specific symptom.
Conclusions: Delays in receiving a diagnosis and worse symptom experience during radiation treatment were demonstrated in this study and may indicate potential targets to improve patient experience.

Figure 1

Figure 2
Loading...